Youjun Xiao

Dr. Youjun Xiao


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in International Immunopharmacology
Verified
Journal Article
Closed access
JWJingnan Wang
Jingnan Wang
RLRuiru Li
Ruiru Li
HLHaobo Lin
Haobo Lin
QQQian Qiu
Qian Qiu
MLMinxi Lao
Minxi Lao
YXYoujun Xiao
Youjun Xiao

27 November 2023 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
YKYu Kuang
Yu Kuang
RLRuiru Li
Ruiru Li
JWJingnan Wang
Jingnan Wang
SXSiqi Xu
Siqi Xu
QQQian Qiu
Qian Qiu
YXYoujun Xiao
Youjun Xiao

9 May 2024 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
DLDi Liu
Di Liu
YKYu Kuang
Yu Kuang
SCSimin Chen
Simin Chen
RLRuiru Li
Ruiru Li
FSFan Su
Fan Su
YXYoujun Xiao
Youjun Xiao
Objective Recent studies indicate that N-acetyltransferase 10 (NAT10)-mediated ac4C modification plays unique roles in tumour metastasis and immune infiltration. This study aimed to uncover the role of NAT10-mediated ac4C in fibroblast-like synoviocytes (FLSs) functions and synovial immune cell infiltration in rheumatoid arthritis (RA). Methods FLSs were obtained from active established patients with RA. Protein expression was determined by western blotting or immunohistochemistry or multiplexed immunohistochemistry. Cell migration was measured using a Boyden chamber. ac4C-RIP-seq combined with RNA-seq was performed to identify potential targets of NAT10. RNA immunoprecipitation was used to validate the interaction between protein and mRNA. NAT10 haploinsufficiency, inhibitor remodelin or intra-articular Adv-NAT10 was used to suppress arthritis in mice with delayed-type hypersensitivity arthritis (DYHA) and collagen II-induced arthritis (CIA) and rats with CIA. Results We found elevated levels of NAT10 and ac4C in FLSs and synovium from patients with RA. NAT10 knockdown or specific inhibitor treatment reduced the migration and invasion of RA FLSs. Increased NAT10 level in the synovium was positively correlated with synovial infiltration of multiple types of immune cells. NAT10 inhibition in vivo attenuated the severity of arthritis in mice with CIA and DTHA, and rats with CIA. Mechanistically, we explored that NAT10 regulated RA FLS functions by promoting stability and translation efficiency of N4-acetylated PTX3 mRNA. PTX3 also regulated RA FLS aggression and is associated with synovial immune cell infiltration. Conclusion Our findings uncover the important roles of NAT10-mediated ac4C modification in promoting rheumatoid synovial aggression and inflammation, indicating that NAT10 may be a potential target for the treatment of RA, even other dysregulated FLSs-associated disorders.

1 April 2022 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
RLRuiru Li
Ruiru Li
WLWei Lin
Wei Lin
YKYu Kuang
Yu Kuang
JWJingnan Wang
Jingnan Wang
SXSiqi Xu
Siqi Xu
XHXu Hanshi
Xu Hanshi
cGAS/STING signaling in the regulation of rheumatoid synovial aggression Ruiru Li, Wei Lin, Yu Kuang, Jingnan Wang, Siqi Xu, Chuyu Shen, Qian Qiu, Maohua Shi, Youjun Xiao, Liuqin Liang, Hanshi Xu

16 July 2024 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
RLRuiru Li
Ruiru Li
YKYu Kuang
Yu Kuang
YNYuanyuan Niu
Yuanyuan Niu
SZShuoyang Zhang
Shuoyang Zhang
SCSimin Chen
Simin Chen
XHXu Hanshi
Xu Hanshi

1 December 2021 in International Immunopharmacology
Verified
Journal Article
Closed access
CSChuyu Shen
Chuyu Shen
YKYu Kuang
Yu Kuang
SXShudi Xu
Shudi Xu
RLRuiru Li
Ruiru Li
JWJingnan Wang
Jingnan Wang
XHXu Hanshi
Xu Hanshi